Unknown

Dataset Information

0

Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma.


ABSTRACT: In multiple myeloma, abnormal plasma cells establish oncogenic niches within the bone marrow by engaging the NF-κB pathway to nurture their survival while they accumulate pro-proliferative mutations. Under these conditions, many cases eventually develop genetic abnormalities endowing them with constitutive NF-κB activation. Here, we find that sustained NF-κB/p52 levels resulting from such mutations favours the recruitment of enhancers beyond the normal B-cell repertoire. Furthermore, through targeted disruption of p52, we characterise how such enhancers are complicit in the formation of super-enhancers and the establishment of cis-regulatory interactions with myeloma dependencies during constitutive activation of p52. Finally, we functionally validate the pathological impact of these cis-regulatory modules on cell and tumour phenotypes using in vitro and in vivo models, confirming RGS1 as a p52-dependent myeloma driver. We conclude that the divergent epigenomic reprogramming enforced by aberrant non-canonical NF-κB signalling potentiates transcriptional programs beneficial for multiple myeloma progression.

SUBMITTER: Ang DA 

PROVIDER: S-EPMC10957915 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma.

Ang Daniel A DA   Carter Jean-Michel JM   Deka Kamalakshi K   Tan Joel H L JHL   Zhou Jianbiao J   Chen Qingfeng Q   Chng Wee Joo WJ   Harmston Nathan N   Li Yinghui Y  

Nature communications 20240321 1


In multiple myeloma, abnormal plasma cells establish oncogenic niches within the bone marrow by engaging the NF-κB pathway to nurture their survival while they accumulate pro-proliferative mutations. Under these conditions, many cases eventually develop genetic abnormalities endowing them with constitutive NF-κB activation. Here, we find that sustained NF-κB/p52 levels resulting from such mutations favours the recruitment of enhancers beyond the normal B-cell repertoire. Furthermore, through tar  ...[more]

Similar Datasets

2024-03-01 | GSE230526 | GEO
2024-03-01 | GSE230296 | GEO
2024-03-01 | GSE230293 | GEO
2024-03-01 | GSE230292 | GEO
2024-03-01 | GSE230466 | GEO
2024-03-01 | GSE230277 | GEO
| PRJNA961705 | ENA
| PRJNA958203 | ENA
| PRJNA958205 | ENA
| PRJNA958202 | ENA